Fact CheckerSign in

NCT07423455Not yet recruiting

Electrotherapeutic Interventions for Glenohumeral Subluxation After Stroke

Comparison of the Clinical and Sonographic Outcomes of NMES and EMG Biofeedback Therapies in Stroke Patients With Glenohumeral Subluxation: Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 20 Feb 2026

Brief summary (registry, in English)

The aim of this single-blind randomized controlled trial is to compare the effects of two therapies-neuromuscular electrical stimulation (NMES) and electromyographic (EMG) biofeedback-in stroke patients with shoulder (glenohumeral) subluxation. The study will evaluate changes in shoulder structure and function by measuring the acromion-greater tuberosity distance, supraspinatus and posterior deltoid muscle thickness, shoulder range of motion, and Brunnstrom stage of the upper extremity and hand. Clinical outcomes such as shoulder pain, stroke-specific quality of life, and the Shoulder Pain and Disability Index (SPADI) will also be assessed. This trial is designed to provide evidence on which therapy may be more effective for improving shoulder stability, reducing pain, and enhancing quality of life in stroke survivors with shoulder subluxation.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
29 Sept 2025
Start date
27 Feb 2026
Primary completion date
27 Sept 2026
Lead sponsor
Şahide Eda ARTUÇ
Diseases
Stroke
NCT number
NCT07423455

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 27 Feb 2026 to the primary completion date, 27 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Steroid injection for shoulder pain within the last 3 months,
  • Presence of metal implants or pacemaker

Other illness

  • Unstable systemic disease,

Other

  • Mini-Mental State Examination (MMSE) score \<24,
  • Visual/hearing impairments, or neglect,
  • Spasticity with Modified Ashworth Scale (MAS) score 3-4,

Who the study is looking for

  • ≥18 years of age,
  • Disease duration \>3 months,
  • Glenohumeral subluxation (GHS) confirmed by ultrasonography (USG),
  • Upper extremity and hand Brunnstrom motor stages between 2 and 5

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gaziler Physical Therapy and Rehabilitation Training and Research Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.